等待開盤 01-29 09:30:00 美东时间
+0.210
+1.54%
DHT Holdings, Inc. (NYSE:DHT) ("DHT" or the "Company") today provides the following business update:For the fourth quarter of 2025, the Company estimates time charter equivalent earnings for its fleet at $60,300 per day,
01-15 05:17
DHT Holdings reported Q4 2025 time charter equivalent earnings of $60,300/day, with VLCCs in spot markets at $69,500/day and time charter VLCCs at $49,400/day, over 1,955 revenue days. In Q1 2026, 45% of spot days booked at $66,300/day, and 66% of total revenue days booked at $51,500/day. President Svein Moxnes Harfjeld noted market tightness and a rebound in spot rates. The company extended the DHT Harrier's charter for 5 years with optional 1-y...
01-14 21:15
周三炼油商和油轮类股票在纽约时段上涨,之前美国表示计划控制委内瑞拉未来的石油销售,并计划将该国多达5000万桶石油移交给美国。炼油股中:Phillips 66上...
01-07 23:24
DHT Holdings, Inc. (NYSE:DHT) ("DHT" or the "Company") today announces that it has entered into an agreement to sell the DHT China and the DHT Europe for a combined price of $101.6 million. Both vessels were built at
2025-12-29 19:58
DHT Holdings has agreed to sell its DHT China and DHT Europe vessels for $101.6 million, with delivery expected in Q1 2026. After repaying $5.6 million in debt, the transaction is expected to generate $95 million in net cash proceeds. The company anticipates booking gains of $30.4 million and $29.7 million from the sales. DHT is an independent crude oil tanker company specializing in VLCC segment vessels, with operations managed through its offic...
2025-12-29 11:57
In this episode of Capital Link's Shipping Sector Webinar Series, we welcomed &...
2025-12-23 21:57
Scorpio Tankers Inc. has signed contracts to build two VLCCs at Hanwha Ocean Co. Ltd. in South Korea, each costing $128 million, with deliveries expected in late 2028. The company has also sold 2.38 million DHT Holdings Inc. shares since October 28, retaining 1.17 million shares. CEO Emanuele Lauro expressed confidence in the crude tanker market's fundamentals, viewing the newbuildings as a strategic investment.
2025-11-11 12:43
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从46美元升至47美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从27美元升至31美元
2025-10-31 10:25
随着全球石油供应增加,且制裁推动对“未受影响”油轮的需求上升,基准油轮的收益已攀升至新冠疫情最严重时期以来的最高水平。
2025-10-30 09:22
今日重点评级关注:HC Wainwright & Co.:维持PepGen"买入"评级,目标价从12美元升至18美元;Piper Sandler:维持Prothena Corp"超配"评级,目标价从15美元升至36美元
2025-10-29 09:25